Back |
home / stock / crmd / crmd message board
Subject | By | Source | When |
---|---|---|---|
Dr. Balauh has already pointed out that they | voisybay123 | investorshub | 03/02/2021 12:20:02 PM |
Manufacturer & label issue will take at least | DavidW2 | investorshub | 03/02/2021 3:06:56 AM |
Good point..I took advantage of the selloff and | Teivel | investorshub | 03/01/2021 11:47:54 PM |
Dont discourage maybe well get some more stupid | namah sivaya | investorshub | 03/01/2021 11:22:00 PM |
* * $CRMD Video Chart 03-01-2021 * * | ClayTrader | investorshub | 03/01/2021 10:13:15 PM |
Did you even read the press release? | Teivel | investorshub | 03/01/2021 9:29:15 PM |
$CRMD will have another dilution before FDA approval. | DavidW2 | investorshub | 03/01/2021 6:23:12 PM |
and what is the likelihood the company has | voisybay123 | investorshub | 03/01/2021 5:26:27 PM |
There is nothing wrong with DefenCath..it's the delivery | Teivel | investorshub | 03/01/2021 3:22:12 PM |
ouch | thumper1 | investorshub | 03/01/2021 2:31:47 PM |
Was expecting some kind of announcement today on | Teivel | investorshub | 02/26/2021 3:03:19 PM |
BlackRock Inc. ownership in $CRMD / CorMedix Inc. 2021-01-29 | Expresso123 | investorshub | 02/26/2021 1:13:55 PM |
Kind of hoping they announce tomorrow as the | Teivel | investorshub | 02/25/2021 8:13:04 PM |
That would be sweeeet! | Teivel | investorshub | 02/25/2021 8:09:39 PM |
We should be able to hit a high | Expresso123 | investorshub | 02/25/2021 7:00:47 PM |
I think we hit 30's...imo. | Teivel | investorshub | 02/25/2021 3:59:08 PM |
still looking for $20-25 IF they get an | timberwolf7 | investorshub | 02/24/2021 10:51:15 PM |
News, Short Squeeze, Breakout and More Instantly...
2024-07-11 12:00:00 ET July 11, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at recent news and developments in the blood infections treatment market, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:C...
BERKELEY HEIGHTS, N.J., July 03, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing therapeutic products for life-threatening diseases and conditions, today announced that it has commenced commercialization of DefenCath ® (tauroli...
BERKELEY HEIGHTS, N.J., June 18, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that the U.S. Food and Drug Administration (FDA) has...